Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.03
+0.18 (2.29%)
At close: Apr 2, 2026, 4:00 PM EDT
7.88
-0.15 (-1.87%)
After-hours: Apr 2, 2026, 7:44 PM EDT

ARCT Revenue

In the year 2025, Arcturus Therapeutics Holdings had annual revenue of $82.03M, down -46.14%. Arcturus Therapeutics Holdings had revenue of $7.20M in the quarter ending December 31, 2025, a decrease of -68.39%.

Revenue (ttm)
$82.03M
Revenue Growth
-46.14%
P/S Ratio
2.78
Revenue / Employee
$739,018
Employees
111
Market Cap
228.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202582.03M-70.28M-46.14%
Dec 31, 2024152.31M-14.49M-8.69%
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 20209.54M-11.25M-54.12%
Dec 31, 201920.79M5.04M31.97%
Dec 31, 201815.75M2.76M21.20%
Dec 31, 201713.00M-7.38M-36.23%
Dec 31, 201620.38M14.24M232.06%
Dec 31, 20156.14M--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Keros Therapeutics244.06M
Compugen72.76M
Fennec Pharmaceuticals44.64M
Voyager Therapeutics40.37M
OmniAb18.67M
MediWound16.96M
Camp4 Therapeutics3.50M
Adagene103.20K
Revenue Rankings